Evaluating the Latest Recommendations in CAD: The Role of Factor Xa Inhibitors

The goal of this activity is to provide an update on the use of factor Xa inhibitors in the management of coronary artery disease (CAD).
 
Educational Partner: Medscape, LLC
 
Medium: Online Presentation
 
Commercial Support: Supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC

Target Audience

This activity is intended for cardiologists, primary care physicians, and surgeons.

Learning Objectives

At the conclusion of this activity, participants will be able to:
 
  • Have increased knowledge regarding the
    • Latest data for factor Xa inhibitors in the setting of stable CAD
    • Latest recommendations on management of stable CAD
Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
For more information, please contact:
CME Coordinator Contact Name: 
Medscape
CME Coordinator Contact Email: 
AttachmentSize
Postcard504.54 KB
Summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
Activity opens: 
12/14/2019
Activity expires: 
12/14/2020

Moderator

Deepak L. Bhatt, MD, MPH

Professor of Medicine
Harvard Medical School
Executive Director of Interventional Cardiovascular Programs
Brigham and Women's Hospital Heart and Vascular Center
Boston, Massachusetts

Panelists

Marc Cohen, MD

Chair, Department of Medicine
Newark Beth Israel Hospital
Professor of Medicine
Rutgers New Jersey Medical School
Newark, New Jersey

David A. Morrow, MD

Director, Levine Cardiac Intensive Care Unit
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Course Reviewer

Matthew Sorrentino, MD, FACC, FAHA

Vice Chair for Clinical Operations
Department of Medicine
Section of Cardiology
University of Chicago Medicine

 

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Physician Credit

The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

Nurse and Other Healthcare Professions Credit

Nurse and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.

 

Registration: To view this activity, you will need to visit Medscape's website.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!
 
Please login or create an account to proceed.